V
主页
Intestinal Bacterial Translocation Contributes to DKD
发布人
打开封面
下载高清视频
观看高清视频
视频下载器
毕业大论文第一章绪论怎么写,视频简介有模板
复杂膈疝修补术(3部分) 博士生导师手术展播
A Variant of Peptide Transporter 2 Predicts the Severity of PAKD
QingReXiaoZheng Formula Modulates Gut Microbiota and Inhibits Inflammation in DKD
基线25-羟基维生素D水平可以预测DKD的肾脏结局
intestinal microbiota control acute kidney injury severity by immune modulation
Compositional alterations of Gut microbiota between the patients with DKD and DM
LncRNA SOX2OT通过Akt/mTOR介导的自噬减轻糖尿病肾病肾小球系膜细胞增殖和纤维化
Concurrent IgA Nephropathy and Membranous Nephropathy
诺欣妥治疗高血压的长期有效性和安全性
Insulin-like Growth Factors and Kidney Disease
IGF1R与哮喘
Targeting the insulin-like growth factor-1 receptor in
LN guideline
MN kdigo guideline
Canagliflozin reduces inflammation and fibrosis biomarkers
Urinary metabolite profiling and risk of progression of DN
Gut microbiota profile and selected plasma metabolites in type 1 diabetes withou
一篇包含了ESRD的肠道菌群、代谢组学、动物实验的文献
利妥昔单抗、环磷酰胺和泼尼松联合治疗原发性膜性肾病
Dapagliflozin in Patients with Chronic Kidney Disease
ANXA1通过促进DN炎症消退减轻肾损伤(Kidney International)
IgAN IgAV- Kdigo Guideline
clinical characteristics and prognosis of Ig D myeloma in the novel agent era
Emerging Modes of Treatment of IgA Nephropathy
饮食、肠道微生物和TMAO
NT157 has antineoplastic effects and inhibits IRS12 and
Moutan Cortex polysaccharide ameliorates diabetic kidney disease via Gut microbe
Anti-GBM GN
The Host Shapes the Gut Microbiota via Fecal microRNA
GLP1(艾塞那肽)和SGLT2(达格列净)与艾塞那肽、达格列净单药比较研究
KP6通过靶向Wnt-βcatenin信号改善糖尿病肾病
biomarkers of inflammation and repair in kidney disease progression
Apixaban versus warfarin in patients with atrial fibrillation and advanced CKD
Molecular Characterization of Membranous Nephropathy
2020-9-25
长非编码RNA lnc-TSI通过负调节TGF-β/ Smad3途径抑制肾纤维化
肠道菌群移植受体小鼠可以部分地重现精神分裂症样表现
Long noncoding RNA H19X is a key mediator of TGFβ driven fibrosis
Rituximab in IMN